Sign Up

About ARALAST NP Therapy

ARALAST NP ARALAST NP

The Alpha Community

As a person who is living with Alpha-1, you are part of a community that has a lot to offer in terms of support, guidance, friendship and sharing. In this section, you'll learn about the resources available to you and ways you can connect.

Learn about some of your fellow Alphas through Real People – Real Stories. Check out the AAT-related announcements and news items from Baxter in the News Room.

In Associations and in Events, you can find out about opportunities to network with other Alphas. You'll find that there are ways to participate locally and nationally, in person and online.

ARALAST NP [Alpha1-Proteinase Inhibitor (Human)]

ARALAST NP is indicated for chronic augmentation therapy in patients having congenital deficiency of A1-PI with clinically evident emphysema. ARALAST NP is not indicated as therapy for lung disease patients in whom congenital A1-PI deficiency has not been established.

The effect of augmentation therapy with ARALAST NP on pulmonary exacerbations and on the progression of emphysema in alpha1-antitrypsin deficiency has not been demonstrated in randomized, controlled clinical trials.

Please review the Important Risk Information and the Full Prescribing Information

Please review the Important Risk Information and the Full Prescribing Information